About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 82 record(s)
Req # A-2023-000981
The Health Canada indication for Medical Device License (MDL) 69955, specifically, the Contour branded indication, Manufacturer PROLLENIUM MEDICAL TECHNOLOGIES INC.Organization: Health Canada
May 2024
Req # A-2023-001536
As part of its application to Health Canada for authorization to sell the COVID-19 lateral flow device with the Interim Order (IO) authorization Identification 327866, the manufacturer sent the federal government about 200 sample tests. Provide the…Organization: Health Canada
May 2024
Req # A-2023-001537
As part of its application to Health Canada for authorization to sell the three COVID-19 lateral flow devices with the Interim Order (IO) authorization Identifications 313054, 328889, and 333956, the manufacturer sent the federal government about…Organization: Health Canada
May 2024
Req # A-2022-001452
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075408-992, Deputy Ministerial Meeting with DNAStack.Organization: Health Canada
May 2024
Req # A-2023-001583
Adverse Drug Reaction (ADR) for Isentress. Report number: E2B_ 00310522.Organization: Health Canada
May 2024
Req # A-2022-001376
All correspondence between Health Canada Office of Pharmaceutical Management Strategies and the Patented Medicine Prices Review Board pertaining to the October 2022 revised draft Guidelines.Organization: Health Canada
May 2023
Req # A-2022-001415
Any internal or external communications from January 1, 2018 to December 31, 2022 involving the Minister of Health or a Health Canada employee at the level of Director General, Assistant Deputy Minister, Associate Deputy Minister, or Deputy Minister…Organization: Health Canada
May 2023
Req # A-2022-001505
A list of all drug manufacturing plants currently banned from producing drugs for the Canadian market. Please include the reason for the ban, the location of the plant and the name of the company running the plant.Organization: Health Canada
May 2023
Req # A-2023-000080
Request to obtain licensing for the product “Reins” - Natural Product Number (NPN): 80003473.Organization: Health Canada
May 2023
Req # A-2020-001132
Adverse Drug Reactions (ADRs) for CABAZITAXEL. Report numbers: E2B_03023776, E2B_03023786.Organization: Health Canada
May 2023